Background and objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal
chemotherapy (HIPEC) can offer selected patients with colorectal peritoneal metastases …

Cytoreduction and heated intraperitoneal chemotherapy (CS/HIPEC) is increasingly utilized
as a treatment strategy for patients with peritoneal metastases from various primary tumor …

For a long time, treatment of peritoneal metastases (PM) was mostly palliative and thus, this
status was link with “terminal status/despair”. The current multimodal treatment strategy …

Background The standardization of surgical outcomes throughout surgical procedures is
mandatory. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS+ …

Patients with peritoneal metastasis from colorectal cancer represent a distinct subset with
regional disease rather than systemic disease. They often have poorer survival outcomes …

目的: 探究腹腔热灌注化疗(HIPEC) 治疗晚期结直肠癌(CRC) 并腹膜转移病人的临床疗效及预后
. 方法: 2016 年4 月~ 2017 年4 月期间内我院收治的CRC 伴腹膜转移病人71 例 …

Simple Summary Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal
chemotherapy improves survival in selected patients with peritoneal metastases from …

Aim: The treatment of peritoneal surface malignancies ranges from palliative care to full
cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy, HIPEC. Ongoing …

Colorectal cancer remains the third most common malignancy in Australia with the
peritoneum being the second most common metastatic site. Colorectal peritoneal …

Multimodal treatment in peritoneal metastases (PM) from colorectal neoplasms may improve
overall survival (OS). In this study, we reported our experience in using cytoreductive …